Institutional investors purchased a net $894.5 thousand shares of INSM during the quarter ended June 2017 and now own 91.91% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GREAT POINT PARTNERS LLC Bought 538.5 Thousand shares of Insmed Inc
GHOST TREE CAPITAL LLC Bought 475.0 Thousand shares of Insmed Inc
CITADEL ADVISORS LLC Bought 269.2 Thousand shares of Insmed Inc